ES8100880A1 - Procedimiento para la fabricacion de una forma de accion re-tardada mejorada. - Google Patents

Procedimiento para la fabricacion de una forma de accion re-tardada mejorada.

Info

Publication number
ES8100880A1
ES8100880A1 ES482496A ES482496A ES8100880A1 ES 8100880 A1 ES8100880 A1 ES 8100880A1 ES 482496 A ES482496 A ES 482496A ES 482496 A ES482496 A ES 482496A ES 8100880 A1 ES8100880 A1 ES 8100880A1
Authority
ES
Spain
Prior art keywords
core
water
coating
contain
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482496A
Other languages
English (en)
Other versions
ES482496A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of ES8100880A1 publication Critical patent/ES8100880A1/es
Publication of ES482496A0 publication Critical patent/ES482496A0/es
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un procedimiento para la fabricación de composiciones de fórmula de cemento Sorel que contienen cloruro de magnesio, óxido de magnesio, agua y una cantidad nucleante de una fórmula de premezcla, que comprende mezclar cloruro de magnesio, óxido de magnesio, agua y una cantidad nucleante de una composición de premezcla que incluye el producto de reacción de agua, cloruro de magnesio y una cantidad relativamente pequeña de óxido de magnesio para proporcionar una composición de cemento Sorel y después de curar dicha composición.
ES482496A 1978-07-15 1979-07-14 Procedimiento para la fabricacion de una forma de accion re-tardada mejorada. Granted ES482496A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782831164 DE2831164A1 (de) 1978-07-15 1978-07-15 Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen

Publications (2)

Publication Number Publication Date
ES8100880A1 true ES8100880A1 (es) 1980-12-01
ES482496A0 ES482496A0 (es) 1980-12-01

Family

ID=6044470

Family Applications (1)

Application Number Title Priority Date Filing Date
ES482496A Granted ES482496A0 (es) 1978-07-15 1979-07-14 Procedimiento para la fabricacion de una forma de accion re-tardada mejorada.

Country Status (4)

Country Link
JP (1) JPS5519257A (es)
DE (1) DE2831164A1 (es)
ES (1) ES482496A0 (es)
HU (1) HU179935B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6082131A (ja) * 1983-10-12 1985-05-10 Nagoya Yukagaku Kogyo Kk フェノール樹脂用微小カプセル型硬化剤
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
BG860Y1 (bg) * 2004-09-17 2007-02-28 "Софарма" Ад Лекарствена форма на дипиридамол
WO2007092026A1 (en) * 2006-02-09 2007-08-16 Teva Pharmaceutical Industries Ltd. Dipyridamole extended-release formulations and process for preparing same

Also Published As

Publication number Publication date
HU179935B (en) 1983-01-28
ES482496A0 (es) 1980-12-01
DE2831164A1 (de) 1980-01-24
JPS5519257A (en) 1980-02-09

Similar Documents

Publication Publication Date Title
SE8404467D0 (sv) Controlled-release medical preparations
SE7906119L (sv) Lekemedel-retardform med olosliga porosa diffusionsholjen
HU908477D0 (en) Process for the production of medical preparations with controlled content of active agents
GB1465781A (en) Pharmaceutical preparations
ATE8459T1 (de) Pharmazeutische zubereitung in form eines polyacrylatfilmes und deren herstellung.
IL88083A (en) Controlled release pharmaceutical dosage form and its preparation
ATE43497T1 (de) Pharmazeutische formulierung mit gesteuerter absorption.
JPS56100714A (en) Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
NO162103C (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
ATE116543T1 (de) Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
DK236388A (da) Mikrogranulaert praeparat, der er anvendeligt til frigoerelse af biologisk aktive materialer i tarmregionerne hos dyr
SE8300577D0 (sv) Overdrag som tillforsekrar reglerad avgivning av akriva bestandsdelar fran biologiskt aktiva blandningar, i synnerhet farmaceutiska beredningar, jemte sett att framstella biologiskt aktiva blandningar med reglerad ....
SE8803822D0 (sv) Novel dosage form
ATE34300T1 (de) Theophyllin mit verlaengerter abgabe.
ES8100880A1 (es) Procedimiento para la fabricacion de una forma de accion re-tardada mejorada.
ES8105145A1 (es) Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal
IE791995L (en) Formulation
JPS5583710A (en) Spongy enzyme preparation
CS185652B2 (en) Insecticide and acaricide agent and mode of manufacture of active substance
ES247237A1 (es) UN MÉTODO PARA LA PREPARACION DE GRáNULOS DE ACCIoN PROLONGADA
JPS579711A (en) Preparation of prolonged release type complex
ATE9957T1 (de) Verfahren zur herstellung eines umhuellten acetylsalicylsaeurepraeparates.
JPS57142913A (en) Donor of physiologically active substance
IT1214658B (it) Esteri polisaccaridici e loro sali
JPS643123A (en) Remedy for skin inflammation